Three-Parent Embryos: Medical World Falls Out Over Eggs, Cells and Terminology
By Steve Connor,
The Independent
| 02. 08. 2015
Untitled Document
It may seem strange that an expert in cloning – the man who produced the first clones of an adult monkey – is now dabbling in a technique that has become widely known as “mitochondrial donation”, a term with the more vulgar moniker of “three-parent” embryos.
Shoukhrat Mitalipov has earned a global reputation as a superb experimentalist able to perform procedures on eggs and embryos that have defied many of his peers. Born in the Soviet Union, in what is now Kazakhstan, and trained in Moscow, Dr Mitalipov, 53, emigrated to the United States in the mid-1990s. Since then he has created shock-waves around the world with his prowess in the manipulation of eggs and embryos.
He now intends to use mitochondrial donation as a treatment for age-related infertility, providing he receives approval for clinical trials.
For many this is confusing, and the reason has much to do with how the scientific terminology surrounding this technique has been subtly manipulated over recent years to make it more publicly acceptable.
Mitochondrial donation is also known as mitochondrial transfer, and...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...